- Home
- SLNH vs DTIL Comparison
SLNH vs DTIL Comparison
Compare SLNH & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNH | DTIL |
|---|---|---|
| Founded | 1961 | 2006 |
| Country | United States | United States |
| Employees | 52 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 214.7M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SLNH | DTIL |
|---|---|---|
| Price | $1.26 | $7.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 13.1M | 456.1K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | $55.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.42 | $3.53 |
| 52 Week High | $5.14 | $9.62 |
Technical Indicators
Market Signals| Indicator | SLNH | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 40.29 |
| Support Level | $1.25 | $6.30 |
| Resistance Level | $1.43 | $7.96 |
| Average True Range (ATR) | 0.12 | 0.50 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 57.50 | 13.72 |
Price Performance
Historical ComparisonAbout SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company engaged in the development and operation of data centers powered by renewable energy. The company utilizes excess or curtailed energy from renewable sources to support high-performance computing applications, including cryptocurrency mining, artificial intelligence, and machine learning. Its business model focuses on converting underutilized renewable energy into computing resources through co-located data center infrastructure.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).